Latest news

Insights

How AI Agents Will Transform Medical Information

Executive Summary Medical Information teams are responsible for providing accurate, balanced, and scientifically appropriate information to healthcare professionals, patients, and...
Insights

Robotics in Pharmaceutical R&D

Executive Summary Pharmaceutical research and development is becoming increasingly automated as companies seek to accelerate experimentation, improve reproducibility, and generate...
Insights

Top 10 Ways AI Is Reducing Drug Commercialization Costs

Executive Summary Commercializing a pharmaceutical product requires substantial investment across market research, launch planning, medical and commercial content, field operations,...
Clinical

Best-in-disease ambitions are fueled by Roche’s GLP-1/GIP medication’s success in a phase 2 diabetic trial

Phase 2 Trial Success for Enicepatide Roche's dual GLP-1/GIP receptor agonist has met its primary endpoints in a phase 2...
Commercial

Boehringer And Envisagenics Sign Huge Multi-Target Oncology Deal

Boehringer Ingelheim has entered a potential $1 billion, multi-year...
Insights

Top 10 Technologies Supporting Multi-Omics Research

Executive Summary Multi-omics research is changing how scientists study complex...
Insights

Digital Endpoints Explained

Executive Summary Clinical trials have traditionally relied on scheduled visits, laboratory assessments, imaging, questionnaires, and other predefined measurements to evaluate...
Commercial

Anthropic Confirms Bay Area Wet Lab as It Expands Life Sciences Efforts

Anthropic has established a wet laboratory in the San Francisco Bay Area as part of its growing life sciences...
Clinical

Bristol Myers Squibb Ends Development of Orum’s ORM-6151 After Phase 1 Review

Bristol Myers Squibb has discontinued development of ORM-6151, a degrader-antibody conjugate (DAC) acquired from South Korean biotechnology company Orum...
Clinical

Phase 3 depression trials halted by Xenon following psychosis episodes

Trial Enrolment Paused Over Neuropsychiatric Adverse Events Xenon Pharmaceuticals has...
Commercial

Telix to Acquire ITM in $1.65 Billion Deal Centered on ITM-11 and Radiopharmaceutical Expansion

Australia-based Telix Pharmaceuticals has agreed to acquire Germany’s ITM...
Regulatory

Beacon Gets Important Trial Win For Vision Loss Treatment; FDA Nod Likely

Beacon Therapeutics has reported a pivotal clinical success for its gene therapy in X-linked retinitis pigmentosa (XLRP), a rare...
Clinical

Despite failing the phase 2 ALS investigation, Axoltis will continue using the synthetic peptide

Phase 2 Trial Overview and Primary Endpoint Results French biotech Axoltis Pharma may have failed to meet its primary endpoint...
Regulatory

BMS and Ono Challenge Amgen as Opdivo Biosimilar Nears FDA Review

Bristol Myers Squibb and Ono Pharmaceutical have filed a lawsuit against Amgen over its proposed biosimilar to the cancer...
Regulatory

Beacon Gets Important Trial Win For Vision Loss Treatment; FDA Nod Likely

Beacon Therapeutics has reported a pivotal clinical success for...
Editorial Team -
Commercial

Boehringer And Envisagenics Sign Huge Multi-Target Oncology Deal

Boehringer Ingelheim has entered a potential $1 billion, multi-year...
Editorial Team -
Commercial

ElevateBio Closes $401M Series D Round, Inks Partnership With Novo Nordisk

The $300 million series A raised by ReNAgade Therapeutics...
Commercial

Clovis Sells Cancer Drug Rubraca for $70 Million amidst Bankruptcy Protection Approval

After filing for bankruptcy last December, Clovis Oncology found...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Suki Launches AI Dictation Tool Integrated With Epic and Meditech EHRs

Suki announced Tuesday the release of Suki Dictation, an artificial intelligence-powered dictation solution designed...
Editorial Team -

Claryx Appears From Stealth to Deal with the $45B Hospital-Acquired Infections Issue

Healthcare-related infections remain a persistent challenge for hospitals, affecting roughly one in every 40...
Editorial Team -

J&J’s OTTAV Robotic Surgical System has received FDA market authorization in the U.S.

The U.S. Food and Drug Administration (FDA) granted Johnson & Johnson De Novo clearance...
Editorial Team -

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Regulatory

Regulatory

Beacon Gets Important Trial Win For Vision Loss Treatment; FDA Nod Likely

Beacon Therapeutics has reported a pivotal clinical success for...
Editorial Team -
Insights

Robotics in Pharmaceutical R&D

Executive Summary Pharmaceutical research and development is becoming increasingly automated...
Insights

Top 10 Ways AI Is Reducing Drug Commercialization Costs

Executive Summary Commercializing a pharmaceutical product requires substantial investment across...
Clinical

Best-in-disease ambitions are fueled by Roche’s GLP-1/GIP medication’s success in a phase 2 diabetic trial

Phase 2 Trial Success for Enicepatide Roche's dual GLP-1/GIP receptor...
Clinical

Immunovant Stops IMVT-1402 Development in Cutaneous Lupus After Trial Misses Primary Endpoint

Immunovant has stopped development of its anti-FcRn antibody IMVT-1402...

Research & Development

Market Access

Manufacturing

Takeda Plans 4,500 Job Cuts as CEO Transition and Three Drug Launches Approach

Takeda has outlined plans to reduce around 4,500 roles...
Manufacturing

Daiichi Revises ADC Supply Plans After Changes in Cancer Drug Demand Forecasts

Daiichi Sankyo said changes in projected demand for several...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

How AI Agents Will Transform Medical Information

Executive Summary Medical Information teams are responsible for providing accurate,...
Editorial Team -
Manufacturing

ArsenalBio Lays Off 99 Employees and Shifts Focus to In Vivo CAR-T Programs

Arsenal Biosciences (ArsenalBio) is reducing its workforce by 99...
Editorial Team -
Insights

Top 10 Ways AI Is Reducing Drug Commercialization Costs

Executive Summary Commercializing a pharmaceutical product requires substantial investment across...
Editorial Team -